Behavioral Intervention for Chronic Disease Prevention
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test the Eat, Move, Live (EML) Program, which seeks to reduce the risk of chronic diseases like cancer by promoting healthier lifestyle habits. Designed for underserved communities, it includes sessions on nutrition, physical activity, and healthy cooking. Participants will learn to eat healthily on a budget, understand food labels, and modify recipes for better health. This trial suits adults who speak English or Spanish and are willing to engage in physical activities. As an unphased trial, it offers a unique opportunity for participants to contribute to valuable research that could enhance community health.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the Eat, Move, Live Program is safe for participants?
Research shows that the Eat, Move, Live (EML) Program is safe for participants. This program aims to improve diet and physical activity, which most people can handle well. Studies on similar programs, such as "Eat Smart, Move More, Weigh Less," have shown positive results, including weight loss, without major side effects. This evidence suggests that joining a lifestyle change program like EML is unlikely to cause harm. Instead, it promotes healthy habits that can help lower the risk of chronic diseases.12345
Why are researchers excited about this trial?
Researchers are excited about the Eat, Move, Live (EML) Program because it offers a holistic approach to preventing chronic diseases, focusing on lifestyle changes rather than medication. Unlike traditional treatments that might involve pharmaceuticals, the EML Program combines weekly educational sessions on nutrition and physical activity with hands-on experiences like cooking and taste tests. This method empowers participants to actively reduce their disease risk through sustainable lifestyle changes, potentially leading to long-lasting health benefits.
What evidence suggests that the Eat, Move, Live Program is effective for reducing the risk of chronic diseases?
Research shows that the Eat, Move, Live (EML) Program, which participants in this trial will attend, can help lower the risk of long-term illnesses. Studies have found that this program encourages healthier lifestyle choices, such as eating better and being more active. Participants in similar programs have lost weight and improved their blood sugar levels, which is important for preventing diseases like diabetes. The EML Program offers culturally relevant education, helping participants learn to read food labels, cook healthy meals, and stay active. By focusing on simple, everyday changes, it aims to reduce the risk of chronic diseases in communities that need it most.12367
Who Is on the Research Team?
Victoria L Seewaldt
Principal Investigator
City of Hope Medical Center
Are You a Good Fit for This Trial?
The Eat, Move, Live Program is for adults over 18 from underserved communities who can speak and understand English or Spanish. It's designed to help reduce cancer and chronic disease risk by teaching healthy lifestyle habits. Participants must be able to engage in physical activity and agree to group consent.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants attend EML program sessions weekly for 12 weeks including an educational session on chronic disease risk reduction via nutrition and physical activity, a physical activity session, and a cooking/taste test demonstration.
Follow-up
Participants are monitored for changes in body measurements, biomarkers, and attitudes and behaviors after the treatment phase.
What Are the Treatments Tested in This Trial?
Interventions
- Eat, Move, Live Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
City of Hope Medical Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator